{"entity":{"type":"insider","cik":"0001650291","url":"/insider/0001650291","json_url":"/insider/0001650291.json","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":17,"first":"2025-08-11","last":"2025-10-20","span_basis":"filed_date"},"name_variants":[{"name":"Decheng Capital China Life Sciences USD Fund II, L.P.","source":"filing","n_filings":17,"first_seen":"2025-08-11","last_seen":"2025-10-20"}],"transactions":[{"id":4534575,"accession":"0001231919-25-000335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000335","line_url":"/filing/0001231919-25-000335#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management II (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45513.0,"shares_display":"45,513","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":80102.88,"total_display":"80,102.88","total_whole":"80,103","shares_owned_after":1518893.0,"shares_owned_after_display":"1,518,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-20","scope":"insider"},{"id":4534571,"accession":"0001231919-25-000335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000335","line_url":"/filing/0001231919-25-000335#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management II (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85798.0,"shares_display":"85,798","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":147572.56,"total_display":"147,572.56","total_whole":"147,573","shares_owned_after":1564406.0,"shares_owned_after_display":"1,564,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-20","scope":"insider"},{"id":4534566,"accession":"0001231919-25-000323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000323","line_url":"/filing/0001231919-25-000323#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17960.0,"shares_display":"17,960","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":29634.0,"total_display":"29,634.00","total_whole":"29,634","shares_owned_after":1650204.0,"shares_owned_after_display":"1,650,204","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-15","scope":"insider"},{"id":4534562,"accession":"0001231919-25-000323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000323","line_url":"/filing/0001231919-25-000323#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28495.0,"shares_display":"28,495","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":47016.75,"total_display":"47,016.75","total_whole":"47,017","shares_owned_after":1668164.0,"shares_owned_after_display":"1,668,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-14","filed_date":"2025-10-15","scope":"insider"},{"id":4534556,"accession":"0001231919-25-000323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000323","line_url":"/filing/0001231919-25-000323#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107361.0,"shares_display":"107,361","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":182513.7,"total_display":"182,513.70","total_whole":"182,514","shares_owned_after":1696659.0,"shares_owned_after_display":"1,696,659","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-15","scope":"insider"},{"id":4493585,"accession":"0001231919-25-000308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000308","line_url":"/filing/0001231919-25-000308#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2390.0,"shares_display":"2,390","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":4230.3,"total_display":"4,230.30","total_whole":"4,230","shares_owned_after":1804020.0,"shares_owned_after_display":"1,804,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-10","filed_date":"2025-10-10","scope":"insider"},{"id":4493581,"accession":"0001231919-25-000308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000308","line_url":"/filing/0001231919-25-000308#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3979.0,"shares_display":"3,979","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":7201.99,"total_display":"7,201.99","total_whole":"7,202","shares_owned_after":1806410.0,"shares_owned_after_display":"1,806,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-09","filed_date":"2025-10-10","scope":"insider"},{"id":4493575,"accession":"0001231919-25-000308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000308","line_url":"/filing/0001231919-25-000308#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7507.0,"shares_display":"7,507","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":13287.39,"total_display":"13,287.39","total_whole":"13,287","shares_owned_after":1810389.0,"shares_owned_after_display":"1,810,389","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4628022,"accession":"0001231919-25-000292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000292","line_url":"/filing/0001231919-25-000292#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":3759.0,"total_display":"3,759.00","total_whole":"3,759","shares_owned_after":1817896.0,"shares_owned_after_display":"1,817,896","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-07","scope":"insider"},{"id":4628017,"accession":"0001231919-25-000292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000292","line_url":"/filing/0001231919-25-000292#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":31150.0,"total_display":"31,150.00","total_whole":"31,150","shares_owned_after":1819996.0,"shares_owned_after_display":"1,819,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-07","scope":"insider"},{"id":4628014,"accession":"0001231919-25-000292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000292","line_url":"/filing/0001231919-25-000292#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":1056.0,"total_display":"1,056.00","total_whole":"1,056","shares_owned_after":1837496.0,"shares_owned_after_display":"1,837,496","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4459276,"accession":"0001231919-25-000278","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000278","line_url":"/filing/0001231919-25-000278#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":1038.0,"total_display":"1,038.00","total_whole":"1,038","shares_owned_after":1838096.0,"shares_owned_after_display":"1,838,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-02","scope":"insider"},{"id":4459271,"accession":"0001231919-25-000278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000278","line_url":"/filing/0001231919-25-000278#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2601.0,"shares_display":"2,601","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":4681.8,"total_display":"4,681.80","total_whole":"4,682","shares_owned_after":1838696.0,"shares_owned_after_display":"1,838,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-02","scope":"insider"},{"id":4459266,"accession":"0001231919-25-000278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000278","line_url":"/filing/0001231919-25-000278#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital Management II (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4464.0,"shares_display":"4,464","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":8079.84,"total_display":"8,079.84","total_whole":"8,080","shares_owned_after":1841297.0,"shares_owned_after_display":"1,841,297","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4628009,"accession":"0001231919-25-000258","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000258","line_url":"/filing/0001231919-25-000258#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":875.0,"total_display":"875.00","total_whole":"875","shares_owned_after":1845761.0,"shares_owned_after_display":"1,845,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-29","scope":"insider"},{"id":4628005,"accession":"0001231919-25-000258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000258","line_url":"/filing/0001231919-25-000258#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":1008.0,"total_display":"1,008.00","total_whole":"1,008","shares_owned_after":1846261.0,"shares_owned_after_display":"1,846,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-29","scope":"insider"},{"id":4627999,"accession":"0001231919-25-000258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000258","line_url":"/filing/0001231919-25-000258#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":1162.0,"total_display":"1,162.00","total_whole":"1,162","shares_owned_after":1846861.0,"shares_owned_after_display":"1,846,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-25","filed_date":"2025-09-29","scope":"insider"},{"id":4798278,"accession":"0001231919-25-000244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000244","line_url":"/filing/0001231919-25-000244#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2256.0,"shares_display":"2,256","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":3790.08,"total_display":"3,790.08","total_whole":"3,790","shares_owned_after":1847561.0,"shares_owned_after_display":"1,847,561","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-24","scope":"insider"},{"id":4798274,"accession":"0001231919-25-000244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000244","line_url":"/filing/0001231919-25-000244#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4106.0,"shares_display":"4,106","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":7062.32,"total_display":"7,062.32","total_whole":"7,062","shares_owned_after":1849817.0,"shares_owned_after_display":"1,849,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-24","scope":"insider"},{"id":4798269,"accession":"0001231919-25-000244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000244","line_url":"/filing/0001231919-25-000244#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5410.0,"shares_display":"5,410","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":9900.3,"total_display":"9,900.30","total_whole":"9,900","shares_owned_after":1853923.0,"shares_owned_after_display":"1,853,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-24","scope":"insider"},{"id":4944265,"accession":"0001231919-25-000221","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231919-25-000221","line_url":"/filing/0001231919-25-000221#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3656.0,"shares_display":"3,656","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":6544.24,"total_display":"6,544.24","total_whole":"6,544","shares_owned_after":1859333.0,"shares_owned_after_display":"1,859,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-19","scope":"insider"},{"id":4944260,"accession":"0001231919-25-000221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231919-25-000221","line_url":"/filing/0001231919-25-000221#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5307.0,"shares_display":"5,307","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":9234.18,"total_display":"9,234.18","total_whole":"9,234","shares_owned_after":1862989.0,"shares_owned_after_display":"1,862,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-19","scope":"insider"},{"id":4944254,"accession":"0001231919-25-000221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000221","line_url":"/filing/0001231919-25-000221#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2304.0,"shares_display":"2,304","price_per_share":1.83,"price_display":"1.83","price_state":"stated","total_value":4216.32,"total_display":"4,216.32","total_whole":"4,216","shares_owned_after":1868296.0,"shares_owned_after_display":"1,868,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-19","scope":"insider"},{"id":4098171,"accession":"0001736814-25-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001736814-25-000007","line_url":"/filing/0001736814-25-000007#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":840.0,"shares_display":"840","price_per_share":1.88,"price_display":"1.88","price_state":"stated","total_value":1579.2,"total_display":"1,579.20","total_whole":"1,579","shares_owned_after":1870600.0,"shares_owned_after_display":"1,870,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-16","scope":"insider"},{"id":4098168,"accession":"0001736814-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001736814-25-000007","line_url":"/filing/0001736814-25-000007#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2570.0,"shares_display":"2,570","price_per_share":1.84,"price_display":"1.84","price_state":"stated","total_value":4728.8,"total_display":"4,728.80","total_whole":"4,729","shares_owned_after":1871440.0,"shares_owned_after_display":"1,871,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4098165,"accession":"0001736814-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001736814-25-000007","line_url":"/filing/0001736814-25-000007#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare GP, LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":1295.0,"total_display":"1,295.00","total_whole":"1,295","shares_owned_after":1874010.0,"shares_owned_after_display":"1,874,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider"},{"id":4359108,"accession":"0001415889-25-024317","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-024317","line_url":"/filing/0001415889-25-024317#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3820.0,"shares_display":"3,820","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":7258.0,"total_display":"7,258.00","total_whole":"7,258","shares_owned_after":1874710.0,"shares_owned_after_display":"1,874,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-11","scope":"insider"},{"id":4359100,"accession":"0001415889-25-024317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-024317","line_url":"/filing/0001415889-25-024317#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8176.0,"shares_display":"8,176","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":15779.68,"total_display":"15,779.68","total_whole":"15,780","shares_owned_after":1878530.0,"shares_owned_after_display":"1,878,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-11","scope":"insider"},{"id":4359096,"accession":"0001415889-25-024317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-024317","line_url":"/filing/0001415889-25-024317#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9050.0,"shares_display":"9,050","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":17828.5,"total_display":"17,828.50","total_whole":"17,829","shares_owned_after":1886706.0,"shares_owned_after_display":"1,886,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider"},{"id":4771031,"accession":"0001415889-25-023907","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023907","line_url":"/filing/0001415889-25-023907#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7090.0,"shares_display":"7,090","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":13683.7,"total_display":"13,683.70","total_whole":"13,684","shares_owned_after":1895756.0,"shares_owned_after_display":"1,895,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-08","scope":"insider"},{"id":4771027,"accession":"0001415889-25-023907","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023907","line_url":"/filing/0001415889-25-023907#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1106.0,"shares_display":"1,106","price_per_share":1.86,"price_display":"1.86","price_state":"stated","total_value":2057.16,"total_display":"2,057.16","total_whole":"2,057","shares_owned_after":1902846.0,"shares_owned_after_display":"1,902,846","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":4771023,"accession":"0001415889-25-023907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023907","line_url":"/filing/0001415889-25-023907#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":803.0,"shares_display":"803","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":1461.46,"total_display":"1,461.46","total_whole":"1,461","shares_owned_after":1903952.0,"shares_owned_after_display":"1,903,952","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":5040468,"accession":"0001415889-25-023607","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023607","line_url":"/filing/0001415889-25-023607#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1270.0,"shares_display":"1,270","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":2298.7,"total_display":"2,298.70","total_whole":"2,299","shares_owned_after":1904755.0,"shares_owned_after_display":"1,904,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-03","scope":"insider"},{"id":5040465,"accession":"0001415889-25-023607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023607","line_url":"/filing/0001415889-25-023607#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":4984.0,"total_display":"4,984.00","total_whole":"4,984","shares_owned_after":1906025.0,"shares_owned_after_display":"1,906,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-03","scope":"insider"},{"id":5040459,"accession":"0001415889-25-023607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023607","line_url":"/filing/0001415889-25-023607#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Cui Xiangmin","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":1392.0,"total_display":"1,392.00","total_whole":"1,392","shares_owned_after":1908825.0,"shares_owned_after_display":"1,908,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-29","filed_date":"2025-09-03","scope":"insider"},{"id":4176699,"accession":"0001415889-25-023258","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023258","line_url":"/filing/0001415889-25-023258#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":809.0,"shares_display":"809","price_per_share":1.81,"price_display":"1.81","price_state":"stated","total_value":1464.29,"total_display":"1,464.29","total_whole":"1,464","shares_owned_after":1909625.0,"shares_owned_after_display":"1,909,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-28","scope":"insider"},{"id":4176697,"accession":"0001415889-25-023258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023258","line_url":"/filing/0001415889-25-023258#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":2314.0,"total_display":"2,314.00","total_whole":"2,314","shares_owned_after":1910434.0,"shares_owned_after_display":"1,910,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-28","scope":"insider"},{"id":4176692,"accession":"0001415889-25-023258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023258","line_url":"/filing/0001415889-25-023258#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Management III (Cayman), LLC; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Healthcare Fund (Master), LP","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":3580.0,"total_display":"3,580.00","total_whole":"3,580","shares_owned_after":1911734.0,"shares_owned_after_display":"1,911,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":4886713,"accession":"0001415889-25-022967","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-022967","line_url":"/filing/0001415889-25-022967#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":531.0,"total_display":"531.00","total_whole":"531","shares_owned_after":1913734.0,"shares_owned_after_display":"1,913,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-25","scope":"insider"},{"id":4886709,"accession":"0001415889-25-022967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022967","line_url":"/filing/0001415889-25-022967#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":4158.0,"total_display":"4,158.00","total_whole":"4,158","shares_owned_after":1914034.0,"shares_owned_after_display":"1,914,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-25","scope":"insider"},{"id":4886704,"accession":"0001415889-25-022967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022967","line_url":"/filing/0001415889-25-022967#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital China Life Sciences USD Fund II, L.P.; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Cui Xiangmin; Decheng Capital Management III (Cayman), LLC","owner_display_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3034.0,"shares_display":"3,034","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":5430.86,"total_display":"5,430.86","total_whole":"5,431","shares_owned_after":1916410.0,"shares_owned_after_display":"1,916,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-25","scope":"insider"},{"id":4246144,"accession":"0001415889-25-022532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-022532","line_url":"/filing/0001415889-25-022532#line-3","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3456.0,"shares_display":"3,456","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":6013.44,"total_display":"6,013.44","total_whole":"6,013","shares_owned_after":1919444.0,"shares_owned_after_display":"1,919,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-20","scope":"insider"},{"id":4246143,"accession":"0001415889-25-022532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022532","line_url":"/filing/0001415889-25-022532#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3604.0,"shares_display":"3,604","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":6379.08,"total_display":"6,379.08","total_whole":"6,379","shares_owned_after":1922900.0,"shares_owned_after_display":"1,922,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-20","scope":"insider"},{"id":4246139,"accession":"0001415889-25-022532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022532","line_url":"/filing/0001415889-25-022532#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC","owner_display_name":"Decheng Capital Management III (Cayman), LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47668.0,"shares_display":"47,668","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":96766.04,"total_display":"96,766.04","total_whole":"96,766","shares_owned_after":1926504.0,"shares_owned_after_display":"1,926,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":5005410,"accession":"0001415889-25-022119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022119","line_url":"/filing/0001415889-25-022119#line-2","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":5800.0,"total_display":"5,800.00","total_whole":"5,800","shares_owned_after":1974172.0,"shares_owned_after_display":"1,974,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":5005404,"accession":"0001415889-25-022119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022119","line_url":"/filing/0001415889-25-022119#line-1","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Management III (Cayman), LLC; Decheng Capital Global Healthcare GP, LLC; Decheng Capital China Life Sciences USD Fund II, L.P.; Cui Xiangmin","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":1977072.0,"shares_owned_after_display":"1,977,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-15","scope":"insider"},{"id":4211915,"accession":"0001415889-25-021441","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001415889-25-021441","line_url":"/filing/0001415889-25-021441#line-17","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2196.0,"shares_display":"2,196","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":4787.28,"total_display":"4,787.28","total_whole":"4,787","shares_owned_after":891734.0,"shares_owned_after_display":"891,734","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-11","scope":"insider"},{"id":4211912,"accession":"0001415889-25-021441","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001415889-25-021441","line_url":"/filing/0001415889-25-021441#line-16","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":1980.0,"total_display":"1,980.00","total_whole":"1,980","shares_owned_after":893930.0,"shares_owned_after_display":"893,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-18","filed_date":"2025-08-11","scope":"insider"},{"id":4211905,"accession":"0001415889-25-021441","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001415889-25-021441","line_url":"/filing/0001415889-25-021441#line-15","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20572.0,"shares_display":"20,572","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":45052.68,"total_display":"45,052.68","total_whole":"45,053","shares_owned_after":894830.0,"shares_owned_after_display":"894,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-08-11","scope":"insider"},{"id":4211903,"accession":"0001415889-25-021441","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001415889-25-021441","line_url":"/filing/0001415889-25-021441#line-14","is_derivative":false,"issuer_cik":"0001487815","issuer_name":"BeyondSpring Inc.","issuer_ticker":"BYSI","issuer_name_source":null,"issuer_url":"/issuer/0001487815","owner_cik":null,"owner_name":"Decheng Capital Global Healthcare Fund (Master), LP; Cui Xiangmin; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Management III (Cayman), LLC; Decheng Capital China Life Sciences USD Fund II, L.P.","owner_display_name":"Decheng Capital Global Healthcare Fund (Master), LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5396.0,"shares_display":"5,396","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":12087.04,"total_display":"12,087.04","total_whole":"12,087","shares_owned_after":915402.0,"shares_owned_after_display":"915,402","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-08-11","scope":"insider"}],"next_cursor":"2025-07-16|4211903","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001677940","name":"BeyondSpring Inc.","url":"/issuer/0001677940","role":"Ten percent owner","n_filings":17,"first_seen":"2025-08-11","last_seen":"2025-10-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650291","retrieved_at":"2026-08-22T05:08:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}